CGON
Price
$25.99
Change
-$0.26 (-0.99%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.98B
29 days until earnings call
IMVT
Price
$16.89
Change
+$0.47 (+2.86%)
Updated
Jul 8 closing price
Capitalization
2.89B
28 days until earnings call
Interact to see
Advertisement

CGON vs IMVT

Header iconCGON vs IMVT Comparison
Open Charts CGON vs IMVTBanner chart's image
CG Oncology
Price$25.99
Change-$0.26 (-0.99%)
Volume$15.25K
Capitalization1.98B
Immunovant
Price$16.89
Change+$0.47 (+2.86%)
Volume$838.54K
Capitalization2.89B
CGON vs IMVT Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. IMVT commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and IMVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (CGON: $25.96 vs. IMVT: $16.89)
Brand notoriety: CGON and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 80% vs. IMVT: 73%
Market capitalization -- CGON: $1.98B vs. IMVT: $2.89B
CGON [@Biotechnology] is valued at $1.98B. IMVT’s [@Biotechnology] market capitalization is $2.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 2 TA indicator(s) are bullish while IMVT’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 2 bullish, 4 bearish.
  • IMVT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -1.48% price change this week, while IMVT (@Biotechnology) price change was +4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

IMVT is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.89B) has a higher market cap than CGON($1.98B). CGON YTD gains are higher at: -9.484 vs. IMVT (-31.813). CGON has higher annual earnings (EBITDA): -134.35M vs. IMVT (-437.78M). IMVT (714M) and CGON (688M) have equal amount of cash in the bank . IMVT has less debt than CGON: IMVT (98K) vs CGON (1.04M). CGON has higher revenues than IMVT: CGON (662K) vs IMVT (0).
CGONIMVTCGON / IMVT
Capitalization1.98B2.89B69%
EBITDA-134.35M-437.78M31%
Gain YTD-9.484-31.81330%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M714M96%
Total Debt1.04M98K1,057%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONIMVT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAAIX39.660.20
+0.51%
Ariel Appreciation Institutional
IGIFX43.000.15
+0.35%
American Funds Intl Gr and Inc F1
AIEVX24.33N/A
N/A
Invesco EQV International Equity R5
TFSCX17.54N/A
N/A
Templeton Ins Foreign Smaller Co Ser Adv
SLARX32.56N/A
N/A
DWS Latin America Equity Inst

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.10%
IDYA - CGON
60%
Loosely correlated
+1.37%
SYRE - CGON
58%
Loosely correlated
+2.03%
ACLX - CGON
57%
Loosely correlated
+1.54%
NUVL - CGON
55%
Loosely correlated
+1.08%
KRYS - CGON
54%
Loosely correlated
+2.57%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+2.86%
ROIV - IMVT
61%
Loosely correlated
+1.12%
OCUL - IMVT
52%
Loosely correlated
+3.23%
XENE - IMVT
50%
Loosely correlated
-1.29%
CGON - IMVT
50%
Loosely correlated
-1.10%
IDYA - IMVT
49%
Loosely correlated
+1.37%
More